miR-30b regulates migration and invasion of human colorectal cancer via SIX1

Author:

Zhao Hui1,Xu Zifeng2,Qin Huanlong3,Gao Zhuo45,Gao Lu67

Affiliation:

1. Department of Surgery and Department of Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China

2. Department of Anesthesiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200080, China

3. Department of Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, China

4. The Center of Metabolic Disease Research, Nanjing Medical University, Nanjing 210029, Jiangsu, China

5. Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201-1192, U.S.A.

6. College of Life Sciences, Northeast Agricultural University, Harbin 150030, Heilongjiang, China

7. Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201-1192, U.S.A.

Abstract

CRC (colorectal cancer) is one of the most malignant tumours in both developing and developed countries. It is estimated that 60% of CRC patients have liver metastasis. In the present study, we show that miR-30b is an important regulator in human CRC migration and invasion, which are vital steps in CRC liver metastasis. miR-30b was significantly down-regulated in primary CRC specimens compared with normal tissues. Furthermore, miR-30b was much lower in liver metastasis tissues than in CRCs. We validated SIX1 (SIX homeobox 1), a member of the SIX homeodomain family of transcription factors and an EMT (epithelial–mesenchymal transition)-promoting gene, as the direct target of miR-30b. Forced expression of miR-30b inhibited CRC cell migration and invasion in vitro via its target gene SIX1. Furthermore, an inverse correlation between expression of SIX1 and miR-30b has been observed both in primary CRC specimens and liver metastasis. Taken together, miR-30b plays an important role in mediating metastatic related behaviour in CRC. miR-30b may serve as a potential diagnostic marker and therapeutic target for patients with CRC in the future.

Publisher

Portland Press Ltd.

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference44 articles.

1. Analysis of the quality of surgical treatment of colorectal cancer, in 2008;Rodriguez-Cuellar;A national study. Cir. Esp.,2010

2. Highlights in metastatic colorectal cancer from the 2012 American Society Of Clinical Oncology Annual Meeting;Grothey;Clin. Adv. Hematol. Oncol.,2012

3. What defines ‘cure’ after liver resection for colorectal metastases? Results after 10 years of follow-up;Pulitano;HPB,2010

4. Resectable colorectal liver metastases: optimal sequencing of chemotherapy;Chua;J. Gastrointest. Cancer.,2012

5. Actual 10-year survival after resection of colorectal liver metastases defines cure;Tomlinson;J. Clin. Oncol.,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3